Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe

Rates of febrile neutropenia with pegfilgrastim on same day versus next day of CHOP with or without rituximab

(2014) Connie Cheng et al.   ANTI-CANCER DRUGS

The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials

(2013) G. H. Lyman et al.   ANNALS OF ONCOLOGY

Pharmacokinetics and Pharmacodynamics of Pegfilgrastim

(2011) Bing-Bing Yang et al.   CLINICAL PHARMACOKINETICS

A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy

(2010) J. Randolph Hecht et al.   Clinical Colorectal Cancer

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

(2010) M.S. Aapro et al.   EUROPEAN JOURNAL OF CANCER

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies

(2010) Howard A. Burris et al.   Journal of Oncology Practice

Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization

(2008) Francesco Crea et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies

(2008) Jenny M. Whitworth et al.   GYNECOLOGIC ONCOLOGY

Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function

(2008) Bing-Bing Yang et al.   JOURNAL OF CLINICAL PHARMACOLOGY